Swiss-Italian Biotech, Philogen Eyes up to 65.3 Million Euros in IPO

ZURICH, Feb 8 (Reuters) - Swiss-Italian biotech group Philogen said it plans to debut on the Milan stock exchange later this month, in Europe's first biotech initial public offering in 2011 and the latest sign appetite for the sector is warming.